| Acquirer | Target | Price |
|---|---|---|
| Allergan plc | Tobira Therapeutics Inc. | $533.6 million |
| Inovalon Holdings, Inc. | Creehan & Company | $105 million |
| Teva Pharmaceutical Industries | Collaboration on fasinumab | $250 million |
| Allergan plc | Akarna Therapeutics Ltd. | $50 million |
| Centric Health Corporation | CareRx Enterprises Ltd. | $14 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
